These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2889658)

  • 21. A dopamine-dependent restitutive system for the maintenance of mental normalcy.
    Friedhoff AJ
    Ann N Y Acad Sci; 1986; 463():47-52. PubMed ID: 2872848
    [No Abstract]   [Full Text] [Related]  

  • 22. Dopamine and schizophrenia.
    Crow TJ; Johnstone EC; Longden A; Owen F
    Adv Biochem Psychopharmacol; 1978; 19():301-9. PubMed ID: 29450
    [No Abstract]   [Full Text] [Related]  

  • 23. Supersensitivity psychosis and tardive dyskinesia: a survey in schizophrenic outpatients.
    Chouinard G; Annable L; Ross-Chouinard A
    Psychopharmacol Bull; 1986; 22(3):891-6. PubMed ID: 2879310
    [No Abstract]   [Full Text] [Related]  

  • 24. The "neuroleptic" antipsychotic drugs. 1. Mechanisms of action.
    Baldessarini RJ
    Postgrad Med; 1979 Apr; 65(4):108-11, 114-9. PubMed ID: 34141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pharmacological and theoretical comparison of high and low potency neuroleptics.
    Zavodnick S
    J Clin Psychiatry; 1978 Apr; 39(4):332-6. PubMed ID: 24619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding and treating psychoses: advances in research and therapy.
    J Clin Psychiatry; 1993 Nov; 54(11):445-52. PubMed ID: 7903666
    [No Abstract]   [Full Text] [Related]  

  • 27. [Neuroleptic malignant syndrome (dopamine-dependent malignant hyperthermia). 4 different cases].
    Truong DD; Sczesni B; Fahn S; Gross J; Donovan K; van Bakel A; Wiley MK
    Nervenarzt; 1988 Feb; 59(2):103-9. PubMed ID: 2896306
    [No Abstract]   [Full Text] [Related]  

  • 28. [New anti-psychotic drugs].
    Lôo H; Brochier T; Meidinger A
    Presse Med; 1991 May; 20(19):889-90. PubMed ID: 1676163
    [No Abstract]   [Full Text] [Related]  

  • 29. Antipsychotic drugs: current use and future prospects.
    Livingston M
    Biomed Pharmacother; 1987; 41(1):34-6. PubMed ID: 2886160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does loxapine have "atypical" properties? Clinical evidence.
    Glazer WM
    J Clin Psychiatry; 1999; 60 Suppl 10():42-6. PubMed ID: 10340686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo neuropharmacology of schizophrenia.
    Bigliani V; Pilowsky LS
    Br J Psychiatry Suppl; 1999; (38):23-33. PubMed ID: 10884897
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics.
    Chouinard G; Jones BD
    Am J Psychiatry; 1980 Jan; 137(1):16-21. PubMed ID: 6101522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
    Lideman RR; Zlobina GP; Mukhin AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacogenetics and schizophrenia.
    Foster A; Miller DD; Buckley PF
    Psychiatr Clin North Am; 2007 Sep; 30(3):417-35. PubMed ID: 17720030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dopamine D4-receptor variants, schizophrenia and clozapine therapy].
    Ewald HL; Mors NP; Rosenberg R
    Ugeskr Laeger; 1996 Jun; 158(25):3601-3. PubMed ID: 8693618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.
    Wiesel FA
    Br J Psychiatry Suppl; 1994 Apr; (23):65-70. PubMed ID: 7913610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiology of schizophrenia: dopamine hypothesis.
    Neylan TC
    J Neuropsychiatry Clin Neurosci; 1996; 8(2):222. PubMed ID: 9081562
    [No Abstract]   [Full Text] [Related]  

  • 38. Neuroleptic-induced supersensitivity psychosis.
    Chouinard G; Jones BD; Annable L
    Am J Psychiatry; 1978 Nov; 135(11):1409-10. PubMed ID: 30291
    [No Abstract]   [Full Text] [Related]  

  • 39. Basic and clinical studies of neuroleptic-induced supersensitivity psychosis and dyskinesia.
    Diamond BI; Borison RL
    Psychopharmacol Bull; 1986; 22(3):900-5. PubMed ID: 2879312
    [No Abstract]   [Full Text] [Related]  

  • 40. Implications of positron emission tomography research for the investigation of the actions of antipsychotic drugs.
    List SJ; Cleghorn JM
    Br J Psychiatry Suppl; 1993 Dec; (22):25-30. PubMed ID: 7906522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.